Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glial fibrillary acidic protein (GFAP) is a type III intermediate filament protein primarily expressed in astrocytes of the central nervous system. It plays a crucial role in providing structural support to astroglia, maintaining the blood-brain barrier integrity, and supporting neighboring neurons. GFAP is upregulated in response to CNS injury or disease, making it a valuable biomarker for various neurological conditions. Mutations in GFAP are associated with Alexander disease, a rare leukodystrophy. It is also explored as a therapeutic target given its implication in astrogliosis and neuroinflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glial Fibrillary Acidic Protein (GFAP).